Global Breakthrough In Treatment Of Dementia ‘Within Reach’ - Clinical Trial In Scotland Recruiting

A Glasgow-based medical research company is leading a worldwide sleep study which could radically reduce the symptoms associated with dementia. The groundbreaking trial, conducted by CPS Research, is the first of its kind to investigate the use of sleep hormone melatonin as an add on treatment for dementia. The study is already showing remarkable initial results in volunteers from Scotland…

Related posts:

1. REM Sleep Disorder Could Be Early Warning Of Parkinson’s, Dementia That Develops Decades Later American n
2. Melatonin Precursor Stimulates Growth Factor Circuits In Brain Scientists
3. New Research Suggests That People With A Sleep Disorder Have A Higher Risk Of Developing Dementia - Alzheimer’s Society Comment People who
4. Somaxon Pharmaceuticals Announces Acceptance Of Phase 3 Clinical Trial Data For Publication In Sleep And Sleep Medicine Somaxon Ph
5. Amazon.com: Sleep Disorders: Diagnosis and Treatment (Current Clinical Amazon.com

Related posts brought to you by Yet Another Related Posts Plugin.